AeroEclipse® II Breath Actuated Nebulizer (BAN) features includes:

• Built-in mode selector provides convenient, easy selection of Breath actuated and Continuous operational modes. Green "feedback" button signals actuation and provides a visual assist to proper use and breathing technique.
• Diaphragm and grid system enhance actuation sensitivity thereby lowering triggering point–only 15 LPM of inspiratory effort is required to trigger the device.
• Mouthpiece can be removed and replaced with Monaghan Medical® disposable or reusable masks, or can be used with an elbow mask adapter to accommodate any standard aerosol mask.
• One-way exhalation valve virtually eliminates the mixing of inspirate and expirate.
• Ergonomic size and shape fit comfortably in the hand. Clarified polypropylene allows easy visualization of molded-in fill lines.
• Molded-in fill lines 0.5 ml to 6 ml.
• One-quarter turn assembly firmly attaches top to cu

The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient's inspiratory flow.  This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments.

Combining the benefits of breath actuation and a superior aerosol particle size, the AeroEclipse® II BAN delivers the industry’s most effective respirable dose. Supported by clinical evidence, the AeroEclipse® II BAN provides approved dosing protocols throughout the hospital and for all patient populations. 

• Breath actuated technology
• Consistent respirable dose
• Virtually no drug is lost to the environment
• Protection from second-hand aerosols
• Minimizes medication waste 
• Efficient treatment times
• Biofeedback button confirms actuation and inhalation 
• Reduced Length of Stay and Admission Rates through the ER1
• Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC 
• Designed and manufactured in North America